返回
Infant Bacterial Therapeutics AB (publ)（IFTBF）价格
IFTBF 股价走势图
IFTBF 收益
Infant Bacterial Therapeutics AB (publ)
$5.47
14.43%
$0.68
截至今日：Jan 29, 10:41:01 GMT-5
Earnings FAQ
IFTBF 最近的每股收益与预期相比如何？
Infant Bacterial Therapeutics AB (publ) IFTBF 上一季度的收入表现如何？
Infant Bacterial Therapeutics AB (publ) 的收入预期是多少？
Infant Bacterial Therapeutics AB (publ) 的盈利质量评分是多少？
Infant Bacterial Therapeutics AB (publ) 何时发布财报？
Infant Bacterial Therapeutics AB (publ) 的预期收益是多少？
Infant Bacterial Therapeutics AB (publ) 是否超出收益预期？
关键数据
前收盘价
$4.78
开盘价
$5.47
当日区间
$5.47 - $5.47
52周范围
$4.78 - $8.2
交易量
--
平均成交量
1.0K
每股收益（TTM）
--
股息收益率
--
市值
$71.2M
什么是 INFANT BACTERIAL THERAPEUTICS A？
Infant Bacterial Therapeutics AB is a clinical stage pharmaceutical company, which engages in the development of drugs for the treatment of rare diseases affecting premature infants. The company is headquartered in Stockholm, Stockholm and currently employs 10 full-time employees. The company went IPO on 2016-03-29. The firm develops drugs that meet the needs of the premature infant. The Company’s focus is on clinical development of IBP-9414, a drug candidate containing Lactobacillus reuteri, in the prevention of necrotizing enterocolitis (NEC), a fatal disease that affects premature infants.